Schizophrenia Clinical Trial
Official title:
Study of the Effectiveness of a Guided Compensatory Cognitive Remediation Program for Family Caregivers in Schizophrenia: a Randomized Pilot Study
Cognitive impairments are extremely common in schizophrenia and strongly predict deficit in
daily functioning, the poor managing medication and multiple hospitalizations. Cognitive
remediation is recognized to have an impact on cognitive impairments by engaging preserved
cognitive functions or by implementing environmental supports that sustain independent
living.
Pr. Velligan (University of San Antonio) developed and tested a manualized intervention,
called Cognitive Adaptation Training. In this program, trained mental health specialists
implement compensatory technique such as environmental supports in the individual's living
environment to live more independently and achieve greater self-sufficiency.
However, implementing this program needs a lot of professionals and time to maintain CAT
effects. This type of intervention is not often done in community care and explains the large
number of patients who are dependent on family members for daily living activities. Training
family members in this form of intervention would be an appropriate way to resolve these
issues. Families expressed a real interest in these types of home-support strategies that CAT
offers. Recently, Pr. Kidd and Pr. Velligan developed a CAT version for families and created
a manual accessible to people without any knowledge of cognitive deficit. This manual helps
families to select specific cognitive-adaptative strategies with their relative to achieve
targeted goals. Thism ethod has been translated in French.
The aim of this study was to examine whether Web-based family Cognitive Adaptation Training
can improve functioning, medication adherence and negative symptoms for individuals with
schizophrenia and reduce burden for family members.
A total of 60 Dyads consisting of one caregiver and one supported individual with
schizophrenia will be randomized to either a Web-based family Cognitive Adaptation Training
or an Internet-based control condition. Primary outcome measured will be the score on the
life skills profile. Secondary outcomes will include the global score of the Zarit burden
Interview, PANSS negative score, and medication adherence.
This type of intervention is expected to be developed in territorial area where professionals
are not trained to cognitive remediation and therefore substantially lowers the barrier to
the deployment of cognitive intervention with other psychosocial interventions for individual
with schizophrenia and their caregivers.
Context and justification It has been shown that when patient's family commits to a
psycho-educational programme, the relapse rate of the patients themselves is halved to an
equivalent level to that of drug treatment. Cognitive disorders affect 80% of patients with
schizophrenia and have deleterious consequences on their autonomy and daily functioning.
Cognitive remediation has now clearly demonstrated its effectiveness in the management of
these cognitive disorders, particularly with regard to compensatory approaches that aim
modifying the environment and providing external support. However, access to cognitive
remediation remains extremely limited. It is only available in a limited number of
specialized centres. In order to allow a better access to these cognitive remediation methods
and to maintain its effects over time, the objective of this research project is to develop a
web-based intervention, the Cognitive Adaptative Training for Caregivers ("CAT famille"),
aimed at accompanying and guiding family carers via an internet video chat with a
psychologist to implement cognitive remediation techniques of compensatory approach directly
into their sick relative living home.
Main and secondary objectives The main objective is to evaluate the impact of a web-based
intervention aimed at training a family caregiver in cognitive remediation techniques using a
compensatory approach on the daily life functioning of his/her family member suffering from
schizophrenia. Secondary objectives are to assess improvement in: 1) caregiver burden, 2)
caregiver and patient quality of life, 3) negative symptoms, and 4) patient compliance.
Methodology This is a comparative, prospective, randomized study including two groups of
(patient/caregiver) dyads: 1) an intervention group consisting of a (patient + family carer)
dyad benefiting, in addition to the usual treatment, from the intervention for the family
carer, and 2) a group consisting of a (patient + caregiver) dyad with usual care (control
group).
Control group: Psycho-education manual, with a weekly reading module and a 15-minute webcam
feedback by the psychologist.
Intervention group: Family CAT manual, with a module each week to be read according to the
patient's objectives and a 15-minute webcam feedback by the psychologist.
For all groups:
Before intervention: Neuropsychological assessment + home assessment of the environment and
the performance of daily living activities by psychologist A.
After intervention: Home assessment of the environment and the performance of daily living
activities by psychologist B.
The inclusion criteria are: 1) for patients: patients with schizophrenia, aged 18 to 50, who
can read, understand and speak French, 2) for parents: understand, speak and read French. The
main outcome will be the assessment of the patient's daily life functioning as measured by
the Life Skills Profile.
Process:
Total number of visits and follow-up: 3 visits during a prospective follow-up over 10 months
Duration of inclusions: 18 months and duration of statistical analysis/valuation: 3-6 months
Feasibility:
The University Service of Adult Psychiatry of the University Hospital of Montpellier is one
of the schizophrenia expert centres of the Fondamental network. SUPA has proven expertise in
the field of cognitive remediation (see PRME Grecco in progress). SUPA works in collaboration
with the family carers of people diagnosed with schizophrenia, in particular through the
Profamille program (psychoeducation for carers) and UNAFAM.
Outcomes / Perspectives:
The management of cognitive disorders is essential in the care of patients with
schizophrenia, in combination with other types of therapies. This research, aimed at training
family carers in the use of compensatory cognitive remediation techniques that require little
knowledge of neuropsychology, will be of direct benefit to patients. The expected results
will contribute to the optimization of management by demonstrating that intervention and
training of relatives in compensatory cognitive techniques will improve functional autonomy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |